The Hidden Dangers of Ketamine Use: Understanding the Risks and Seeking Help

Ketamine has shifted from being a specialist anaesthetic used in surgery to a common recreational drug, particularly among younger adults in the UK. Its reputation as a “party drug” or a means to escape emotional pain hides a darker side: growing evidence shows that frequent ketamine use can lead to serious physical, mental, and social harms.

Across England, including Cheshire and Greater Manchester, ketamine use has increased over the past decade. In England, 5,365 adults started treatment for ketamine problems in 2024–25, more than 12 times the 426 who did so in 2014–15 (Office for Health Improvement and Disparities, 2025). For some, what starts as experimental use can become a pattern of dependence, withdrawal, and worsening wellbeing.

This article explores the risks and difficulties associated with ketamine use, and how Cheshire Sobriety Clinic can support recovery through an integrated approach combining Rapid Transformational Therapy® (RTT®) and talking therapy.

Understanding Ketamine and How It Works

Ketamine is classified as a dissociative anaesthetic. It alters perception of pain, body awareness, and reality. At medical doses, it is used for pain control and anaesthesia, but at recreational doses, it can induce hallucinations, out-of-body experiences, and detachment from self and surroundings (Morgan & Curran, 2012).

Its main mechanism involves blocking NMDA (N-methyl-D-aspartate) receptors in the brain. These receptors play a role in memory, emotion, and learning. This mechanism explains why users report profound distortions in perception and why long-term use can affect memory and cognition (Mion & Villevieille, 2013).

Although ketamine has recently gained attention for potential antidepressant effects at controlled doses in medical settings, recreational or unsupervised use carries very different risks.

Physical Health Risks

Urinary and Bladder Damage

Repeated ketamine use can cause ulcerative cystitis, an extremely painful and debilitating condition that affects the bladder and urinary tract. Symptoms include urinary urgency, blood in urine, incontinence, and chronic pelvic pain (Chu et al., 2008). In severe cases, individuals may require surgical intervention or bladder removal (Morgan & Curran, 2012). UK hospitals, including in the North West, have reported a surge in young people presenting with “ketamine bladder,” a term used by clinicians to describe these symptoms (Wood et al., 2011).

If you have bladder pain, blood in your urine or need to pass urine urgently, see your GP.

Liver and Gastrointestinal Damage

Chronic ketamine use has also been linked to liver inflammation and biliary tract abnormalities. Studies suggest that high-dose, long-term users show elevated liver enzymes and structural changes similar to gallbladder disease (Lo et al., 2011).

Cognitive Impairment

Research shows that prolonged ketamine use impairs memory, attention, and executive functioning. Morgan et al. (2010) followed chronic users over a year and found measurable declines in spatial memory and pattern recognition. This means users can struggle with concentration, planning, and learning, making it difficult to work, study, or sustain relationships.

Physical Injury

During intoxication, users may lose coordination and spatial awareness, increasing the risk of falls or accidents. Dissociative experiences may also lead to risky behaviour, as pain sensitivity and danger awareness are diminished (Corazza et al., 2012).

Mental Health and Psychological Effects

Depression and Emotional Instability

While low-dose ketamine under medical supervision is being studied as a rapid-acting antidepressant, recreational use shows the opposite effect. Studies demonstrate that frequent, unsupervised use increases rates of depression, anxiety, and mood instability (UCL News, 2025).

Dissociation and Trauma

Ketamine induces intense dissociative states, often described as entering a “K-hole.” These experiences can be frightening or traumatic, especially for those with prior mental health issues. Repeated dissociation may lead to emotional numbing and difficulty connecting with reality or relationships (Morgan & Curran, 2012).

Psychosis and Hallucinations

Repeated use can trigger psychotic-like symptoms such as paranoia or auditory hallucinations. Beck et al. (2020) found that ketamine administration significantly increases positive psychotic symptoms, even in healthy individuals. For those with a predisposition to schizophrenia or bipolar disorder, these effects can be longer lasting.

Dependence and Craving

Ketamine was once thought to carry minimal dependence potential, but newer evidence shows that psychological dependence can develop rapidly. Users often report cravings and loss of control over use despite negative consequences (Morgan & Curran, 2012).

Social and Behavioural Consequences

Impact on Relationships and Work

Cognitive and emotional blunting make it harder to maintain stable relationships, perform consistently at work, or pursue goals. Many users report drifting away from family or friends, experiencing isolation and shame.

Risk-Taking and Accidents

Under the influence, ketamine can impair judgement, increasing the risk of accidents or unsafe sex. In nightlife settings, users may be unaware of injury, dehydration, or overdose (Winstock et al., 2012).

Legal and Social Impacts

As a Class B controlled substance under the Misuse of Drugs Act (1971), possession or supply carries serious legal consequences. A criminal record can further isolate individuals, reducing employment and housing opportunities (Home Office, 2024).

Recent Data: England and Greater Manchester

The share of adults starting treatment in England for ketamine problems rose from 2.3% in 2023–24 to 3.2% in 2024–25 (Office for Health Improvement and Disparities, 2025).

In Greater Manchester, the GM TRENDS 2023–24 monitoring report found that 16% of the 400 young people it surveyed had used ketamine in the past year, up from about 6% the year before. Of the 132 professionals surveyed, 42% worked with people who use ketamine, and nearly two-thirds of those (63%) had seen use increase. Treatment data from seven of the ten Greater Manchester areas showed 77 young people in treatment for ketamine, almost two-thirds of them under 18, with some already needing urology care (GM TRENDS, 2024).

These trends highlight a growing need for specialist, local interventions capable of addressing both the physical and psychological dimensions of ketamine use.

Why Recovery Can Be Difficult

Quitting ketamine involves unique challenges:

1. Cognitive deficits – Memory and focus problems make therapy engagement and self-management harder (Morgan et al., 2010).

   
   

2. Emotional instability – Post-use mood swings and dissociation can create distress that drives relapse.

   
   

3. Social reinforcement – Ketamine use is often embedded in social scenes where abstinence feels isolating.

   
   

4. Lack of pharmacological treatment – There are currently no approved medications for ketamine dependence, so psychological therapy remains the cornerstone of care.

   
   

5. Stigma and shame – Fear of judgement deters many from seeking help early.

   
   

How Cheshire Sobriety Clinic Can Help

At Cheshire Sobriety Clinic, we understand that ketamine use is rarely just about the drug itself. Often it is tied to emotional pain, trauma, or stress management. Our approach combines Rapid Transformational Therapy® (RTT®) with evidence-based talking therapy, working with both the subconscious and conscious factors behind substance use.

Rapid Transformational Therapy® (RTT®)

RTT® aims to access the subconscious mind to uncover and reframe the beliefs or experiences underpinning substance use. Many clients using ketamine report feeling emotionally detached, unworthy, or overwhelmed by trauma. RTT® aims to challenge and replace these deep-seated patterns. There are not yet any controlled trials of RTT® for ketamine or other drug problems.

Talking Therapy

We integrate Motivational Interviewing (MI) and Relapse Prevention Therapy. These methods teach practical coping skills, develop insight into triggers, and build new ways to manage stress without resorting to dissociation or substance use.

Your Mental Health Is Part of the Plan

Because ketamine use often co-occurs with anxiety, depression, or trauma, your treatment plan takes account of these too, and we work alongside your GP or NHS mental health team where needed.

Cognitive Support and Adapted Sessions

For clients experiencing memory or focus problems, sessions are structured with summaries and flexible pacing. This ensures therapy remains accessible, even when cognition is affected.

Long-Term Recovery and Relapse Prevention

Sustained recovery requires structure and ongoing support. We help clients rebuild healthy routines, social networks, and daily habits that reinforce wellbeing. Between sessions, you listen to a personalised RTT® recording every day for at least 21 days. Aftercare is included in our Full Treatment Programme and Private Client programme.

Conclusion

Ketamine is not a harmless party drug. Regular or heavy use can lead to serious physical, mental, and emotional harm, affecting the bladder, brain, mood, and relationships. Yet recovery is possible.

At Cheshire Sobriety Clinic, our integrated approach of RTT® and talking therapy offers a compassionate, structured route towards recovery. We work on the causes beneath the behaviour and on practical tools for managing life’s stresses.

If ketamine use is affecting your life, or that of someone you love, reach out today. Recovery starts with a single step. That step doesn't need to be perfect. It just needs to be yours.

Cheshire Sobriety Clinic provides private outpatient therapy. We do not provide medically managed detox, crisis care or psychiatric treatment. If you drink heavily every day, don’t stop suddenly without medical advice: speak to your GP or call NHS 111. In an emergency, call 999. RTT® and hypnosis may not be suitable if you have a history of psychosis, and we will talk this through at your consultation. Everyone’s experience of treatment is different, and results can’t be guaranteed.

References

Chu, P. S. K., Kwok, S. C. H., Lam, K. M., Chu, T. Y., Chan, S. W., Man, C. W. and Yu, M. K. (2008) ‘The destruction of the lower urinary tract by ketamine abuse: a new syndrome?’, BJU International, 102(11), pp. 1616–1622.

Corazza, O., Schifano, F., Simonato, P., Fergus, S., Assi, S. and Stair, J. (2012) ‘Phenomenon of ketamine misuse in the UK: findings from an online survey’, Human Psychopharmacology: Clinical and Experimental, 27(3), pp. 254–259.

GM TRENDS (2024) Trend focus: ketamine. Greater Manchester Testing and Research on Emergent and New Drugs, 2023–2024 monitoring cycle. Manchester: Manchester Metropolitan University. Available at: https://gmtrends.mmu.ac.uk/

Home Office (2024) Misuse of Drugs Act 1971: Controlled Drugs Classification. London: Home Office.

Lo, R. S., Krishnamoorthy, R., Freeman, R. and Macdonald, S. (2011) ‘Biliary tract and liver abnormalities in ketamine users’, Clinical Radiology, 66(9), pp. 854–858.

Mion, G. and Villevieille, T. (2013) ‘Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)’, CNS Neuroscience & Therapeutics, 19(6), pp. 370–380.

Morgan, C. J., Muetzelfeldt, L. and Curran, H. V. (2010) ‘Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study’, Addiction, 105(1), pp. 121–133.

Morgan, C. J. and Curran, H. V. (2012) ‘Ketamine use: a review’, Addiction, 107(1), pp. 27–38.

Beck, K., Hindley, G., Borgan, F. et al. (2020) ‘Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis’, JAMA Network Open, 3(5), e204693.

Office for Health Improvement and Disparities (2025) Adult substance misuse treatment statistics 2024 to 2025: report. London: OHID.

UCL News (2025) ‘Physical and psychological symptoms of ketamine abuse revealed’. University College London, 12 April. Available at: https://www.ucl.ac.uk/news/2025/apr/physical-and-psychological-symptoms-ketamine-abuse-revealed (Accessed: 3 November 2025).

Winstock, A. R., Mitcheson, L., Gillatt, D. A. and Cottrell, A. M. (2012) ‘The prevalence and natural history of urinary symptoms among recreational ketamine users’, BJU International, 110(11), pp. 1762–1766.

Wood, D., Cottrell, A., Baker, S.C., Southgate, J., Harris, M., Fulford, S., Woodhouse, C. and Gillatt, D. (2011) ‘Recreational ketamine: from pleasure to pain’, BJU International, 107(12), pp. 1881–1884.

© 2025 Cheshire Sobriety Clinic. All rights reserved.